1. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry. Antibacterial drug products: use of noninferiority studies to support approval. Draft guidance. October 2007. Available at: http://www.fda.gov/cder/guidance/7884dft.pdf. Accessed 7 October 2008.
2. Antimicrobial Resistance: Pharmacokinetics‐Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice Anymore
3. Arguedas A, Dagan R, Wang E, etal Dose-efficacy of faropenem in the treatment of acute otitis media using double tympanocentesis in obtained middle ear fluid [abstract G-987]. In: Program and abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2007:273.
4. Raxar (grepafloxacin hydrochloride tablets) clinical pharmacology. Available at: http://www.rxlist.com/cgi/generic/grepa_cp.htm. Accessed 7 October 2008
5. Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis